Status: Recruiting
Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD
A phase 2, multicentre, randomized, double-blind, placebo-controlled, parallel group study to evaluate the effect of tezepelumab on airway inflammation in patients with COPD.
Participants needed: 80
Trial details
Phase: Phase 2Age: 40+Biological sex: AllType: InterventionalSponsor: Asger SverrildUpdated: Aug 21, 2024Locations: 2
Eligibility criteria
Written informed consent [+9]
Previous medical history or evidence of an uncontrolled intercurrent illness tha... [+23]